Effect of alendronate (bisphosphonate) in animal models of hyperparathyroidism.
Thompson
D D
DD
Department of Bone Biology and Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, Pa.
Seedor
J G
JG
Grasser
W
W
Rosenblatt
M
M
Rodan
G A
GA
D019386:Alendronate; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000139:chemically induced; D002118:Calcium / Q000097:blood; D004164:Diphosphonates / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010010:Osteoclasts / Q000187:drug effects; D010281:Parathyroid Hormone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D004164:Diphosphonates; D010281:Parathyroid Hormone; D002118:Calcium; D019386:Alendronate